Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: GINKGO BIOWORKS, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-07-30 to 2020-11-10
Current total value of award: $6574473.6
Description: RAPID ACCELERATION OF DIAGNOSTICS (RADX) ADVANCED TECHNOLOGY PLATFORMS (ATP)- THE RADX-ATP PROGRAM SEEKS TO INCREASE TESTING CAPACITY AND THROUGHPUT BY IDENTIFYING EXISTING TESTING PLATFORMS FOR SARS-COV-2 TESTING.